Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 346

1.

Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.

Hammond A, Andus T, Gierend M, Ecker KW, Scholmerich J, Herfarth H; German Budesonide Foam Study Group..

Hepatogastroenterology. 2004 Sep-Oct;51(59):1345-9.

PMID:
15362749
3.

Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis.

Hartmann F, Stein J; BudMesa-Study Group..

Aliment Pharmacol Ther. 2010 Aug;32(3):368-76. doi: 10.1111/j.1365-2036.2010.04354.x. Epub 2010 May 11.

4.

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.

Gross V, Bar-Meir S, Lavy A, Mickisch O, Tulassay Z, Pronai L, Kupcinskas L, Kiudelis G, Pokrotnieks J, Kovács A, Faszczyk M, Razbadauskas A, Margus B, Stolte M, Müller R, Greinwald R; International Budesonide Foam Study Group..

Aliment Pharmacol Ther. 2006 Jan 15;23(2):303-12.

5.

Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.

Hanauer SB, Robinson M, Pruitt R, Lazenby AJ, Persson T, Nilsson LG, Walton-Bowen K, Haskell LP, Levine JG.

Gastroenterology. 1998 Sep;115(3):525-32.

PMID:
9721148
6.

Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.

Biancone L, Gionchetti P, Blanco Gdel V, Orlando A, Annese V, Papi C, Sostegni R, D'Incà R, Petruzziello C, Casa A, Sica G, Calabrese E, Campieri M, Pallone F.

Dig Liver Dis. 2007 Apr;39(4):329-37. Epub 2007 Mar 7.

PMID:
17347061
7.

Budesonide versus prednisolone retention enemas in active distal ulcerative colitis.

Löfberg R, Ostergaard Thomsen O, Langholz E, Schiöler R, Danielsson A, Suhr O, Graffner H, Påhlman L, Matzen P, Møller-Petersen JF, et al.

Aliment Pharmacol Ther. 1994 Dec;8(6):623-9. Erratum in: Aliment Pharmacol Ther 1995 Apr;9(2):213.

PMID:
7696452
8.

Budesonide foam vs. hydrocortisone acetate foam in the treatment of active ulcerative proctosigmoiditis.

Bar-Meir S, Fidder HH, Faszczyk M, Bianchi Porro G, Sturniolo GC, Mickisch O, Müller R, Greinwald R, Chowers Y, Grobeta V; International Budesonide Study Group..

Dis Colon Rectum. 2003 Jul;46(7):929-36.

PMID:
12847368
9.

Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis.

Lémann M, Galian A, Rutgeerts P, Van Heuverzwijn R, Cortot A, Viteau JM, Elewaut A, Belaiche J, Froguel E, Modigliani R.

Aliment Pharmacol Ther. 1995 Oct;9(5):557-62.

PMID:
8580278
10.

A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis.

Lee FI, Jewell DP, Mani V, Keighley MR, Kingston RD, Record CO, Grace RH, Daniels S, Patterson J, Smith K.

Gut. 1996 Feb;38(2):229-33.

11.

Budesonide enema in pouchitis--a double-blind, double-dummy, controlled trial.

Sambuelli A, Boerr L, Negreira S, Gil A, Camartino G, Huernos S, Kogan Z, Cabanne A, Graziano A, Peredo H, Doldán I, Gonzalez O, Sugai E, Lumi M, Bai JC.

Aliment Pharmacol Ther. 2002 Jan;16(1):27-34.

12.

Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.

Ardizzone S, Doldo P, Ranzi T, Sturniolo GC, Giglio LA, Annese V, D'Arienzo A, Gaia E, Gullini S, Riegler G, Valentini M, Massa P, Del Piano M, Rossini F, Guidetti CS, Pera A, Greinwald R, Bianchi Porro G.

Ital J Gastroenterol Hepatol. 1999 Nov;31(8):677-84.

PMID:
10730559
14.

Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study.

Pokrotnieks J, Marlicz K, Paradowski L, Margus B, Zaborowski P, Greinwald R.

Aliment Pharmacol Ther. 2000 Sep;14(9):1191-8.

15.

A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis.

Danielsson A, Hellers G, Lyrenäs E, Löfberg R, Nilsson A, Olsson O, Olsson SA, Persson T, Salde L, Naesdal J, et al.

Scand J Gastroenterol. 1987 Oct;22(8):987-92.

PMID:
3317784
16.
17.

A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.

Mantzaris GJ, Archavlis E, Christoforidis P, Kourtessas D, Amberiadis P, Florakis N, Petraki K, Spiliadi C, Triantafyllou G.

Am J Gastroenterol. 1997 Mar;92(3):454-6.

PMID:
9068468
18.

Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.

Eliakim R, Tulassay Z, Kupcinskas L, Adamonis K, Pokrotnieks J, Bar-Meir S, Lavy A, Mueller R, Greinwald R, Chermesh I, Gross V; International Salofalk Foam Study Group..

Aliment Pharmacol Ther. 2007 Nov 1;26(9):1237-49.

19.

Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis.

Löfberg R, Danielsson A, Suhr O, Nilsson A, Schiöler R, Nyberg A, Hultcrantz R, Kollberg B, Gillberg R, Willén R, Persson T, Salde L.

Gastroenterology. 1996 Jun;110(6):1713-8.

PMID:
8964395
20.

A controlled trial of beclomethasone versus betamethasone enemas in distal ulcerative colitis.

Halpern Z, Sold O, Baratz M, Konikoff F, Halak A, Gilat T.

J Clin Gastroenterol. 1991 Feb;13(1):38-41.

PMID:
2007742

Supplemental Content

Support Center